rfhg_207253.1

Basic information about the TSS

---

TSS ID: rfhg_207253.1 TSS ID(Version3): hg_179018.1 hg_179017.1 Species: human Chr: chr19		Start: 9584494 End: 9584545 Strand: -
Source datasets	FANTOM5|DBTSS|PRJNA615891|PRJNA401781|PRJDB5282 |PRJNA4843412|PRJNA548673|PRJNA597322|DRA013844
Protocol	CAGE|TSS-seq|TIF-seq2|RAMPAGE|SLIC_CAGE|C1CAGE |oligo_capping|NETCAGE|ReCappable-seq|STRIPE-seq
TSS cluster detected*	13

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	PLS,CTCF-bound (EH38D3039990,EH38E1937691)
Category:	PLS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: ENST00000320451.7:0 ENST00000586602.5:0 AK297919:0 GeneID: 7675 HGNC/MGI_ID: HGNC:12904 UniProt_ID: B4DNH5 P58317 Nearer transcript ids and distances: AK025435:3

Gene_name: zinc finger protein 121 Gene_symbol: ZNF121 Gene_synonyms: ZHC32 ZNF20 Gene_source: HGNC:12904

TATA-Box annotation

---

Distance to TSS:	-15
Nearest PromoterID:	NM_001008727
Entrez ID:	7675
Nearest Unigene:	Hs.501537
Nearest Refseq:	NM_001008727
Nearest Ensembl:	ENSG00000197961
Gene Name:	zinc finger protein 121
Gene Alias:	D19S204|ZHC32|ZNF20
Gene Type:	protein-coding
CpG%:	0.098039
GC%:	0.596154
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@ZNF121 p2@ZNF121
Sample		p1@ZNF121	p2@ZNF121
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	78.51	26.10
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	68.38	20.23
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	79.09	25.66
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	77.34	23.70
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	78.06	24.30
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	84.31	22.68
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	94.13	34.43
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	71.45	26.40
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	52.57	20.73
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	132.15	53.33
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	111.97	41.64
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	136.60	52.04
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	13.38	7.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	13.23	9.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	14.05	8.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	12.07	10.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	13.32	7.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	17.72	6.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	13.86	12.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	15.50	6.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	10.02	5.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	13.29	7.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	13.83	8.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	13.10	6.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	16.25	7.74
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	11.39	6.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	18.13	7.14
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	17.45	9.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	12.28	5.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	15.74	9.05
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	10.89	7.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	12.70	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	10.97	4.85
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	13.69	5.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	11.59	4.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	11.31	4.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	9.81	6.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	8.66	4.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	8.91	3.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	11.28	5.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	9.18	2.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	11.57	4.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	8.86	4.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	8.39	3.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	11.24	5.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	8.14	4.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	8.88	3.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	9.84	2.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	8.86	4.07
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	9.30	3.03
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	8.61	8.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	8.89	7.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	41.98	55.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	11.00	3.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	10.27	5.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	26.01	20.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	11.94	9.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	9.72	8.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	9.31	6.10
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	11.32	12.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	10.58	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	9.53	5.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	11.15	17.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	13.59	9.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	14.30	6.82
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	11.71	3.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	32.33	48.49
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	78.97	110.56
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	12.68	9.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	17.36	4.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	14.54	7.51
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	13.58	7.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	11.45	10.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	8.26	9.48
Adipocyte - breast, donor1	11376-118A8	8.08	2.85
Adipocyte - breast, donor2	11327-117E4	7.38	3.69
Adipocyte - omental, donor1	11473-119C6	10.56	7.12
Adipocyte - omental, donor2	11474-119C7	3.74	1.49
Adipocyte - omental, donor3	11475-119C8	5.69	2.68
Adipocyte - perirenal, donor1	11476-119C9	3.83	6.38
Adipocyte - subcutaneous, donor1	11259-116F8	5.50	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	5.87	3.16
Adipocyte - subcutaneous, donor3	11408-118E4	5.73	2.26
Adipocyte differentiation, day04, donor1	13019-139D4	16.82	8.02
Adipocyte differentiation, day04, donor2	13022-139D7	14.93	3.35
Adipocyte differentiation, day04, donor3	13025-139E1	11.43	4.74
Adipocyte differentiation, day04, donor4	13028-139E4	8.82	5.29
Adipocyte differentiation, day08, donor1	13020-139D5	20.11	9.65
Adipocyte differentiation, day08, donor2	13023-139D8	12.59	6.78
Adipocyte differentiation, day08, donor3	13026-139E2	9.60	5.87
Adipocyte differentiation, day08, donor4	13029-139E5	8.35	6.12
Adipocyte differentiation, day12, donor1	13021-139D6	6.65	3.33
Adipocyte differentiation, day12, donor2	13024-139D9	11.80	4.52
Adipocyte differentiation, day12, donor3	13027-139E3	8.18	3.93
Adipocyte differentiation, day12, donor4	13030-139E6	5.78	3.35
Alveolar Epithelial Cells, donor1	11510-119G7	5.08	1.77
Alveolar Epithelial Cells, donor2	11590-120G6	1.79	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	1.20	1.20
Amniotic Epithelial Cells, donor1	11533-120A3	4.14	2.52
Amniotic Epithelial Cells, donor2	11613-122A2	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	2.67	1.64
Anulus Pulposus Cell, donor1	11248-116E6	9.15	6.64
Anulus Pulposus Cell, donor2	11463-119B5	4.65	5.39
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	8.99	4.04
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	6.95	5.21
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	6.42	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	9.57	3.89
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	6.32	8.85
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	5.94	8.58
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	6.17	4.55
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	5.83	6.31
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	2.38	7.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	7.16	3.77
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	7.26	5.08
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	1.25	5.02
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	7.91	4.45
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	9.55	2.73
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	6.94	4.07
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	6.43	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	6.42	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	6.41	5.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	0.98	4.88
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	7.13	4.81
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	4.80	8.41
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	7.08	7.08
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	6.52	3.77
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	5.34	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	5.31	6.07
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	4.85	4.85
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	5.13	3.99
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	5.77	3.63
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	3.61	3.87
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	7.51	6.10
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	9.00	3.54
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	4.28	3.57
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	8.77	6.43
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	6.62	4.22
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	2.38	7.13
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	6.61	8.65
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	8.40	6.62
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	3.81	5.08
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	7.77	3.02
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	8.26	3.39
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	4.93	4.64
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	8.50	0.94
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	3.73	3.39
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	11.58	2.32
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	8.45	4.23
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	4.07	3.22
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	4.21	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	6.56	4.37
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	5.29	5.98
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	5.10	7.65
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	4.32	3.31
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	5.57	4.54
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	6.12	4.59
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	8.13	4.78
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	5.99	2.44
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	6.10	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	5.54	2.77
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	4.77	3.44
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	3.63	2.91
Astrocyte - cerebellum, donor1	11500-119F6	7.37	3.81
Astrocyte - cerebellum, donor2	11580-120F5	3.25	1.03
Astrocyte - cerebellum, donor3	11661-122F5	2.10	0.63
Astrocyte - cerebral cortex, donor1	11235-116D2	21.61	6.97
Astrocyte - cerebral cortex, donor2	11316-117D2	19.57	7.93
Astrocyte - cerebral cortex, donor3	11392-118C6	22.22	11.19
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	44.50	33.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	48.36	33.20
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	50.87	34.03
Basophils, donor1	12241-129G9	7.32	1.83
Basophils, donor2	12242-129H1	24.89	16.96
Basophils, donor3	12243-129H2	7.64	3.67
Bronchial Epithelial Cell, donor1	11511-119G8	4.31	2.16
Bronchial Epithelial Cell, donor2	11591-120G7	1.83	0.91
Bronchial Epithelial Cell, donor3	11672-122G7	14.35	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	10.04	6.28
Bronchial Epithelial Cell, donor5	11457-119A8	6.65	2.29
Bronchial Epithelial Cell, donor6	11461-119B3	6.91	5.53
Bronchial Epithelial Cell, donor7	11769-123I5	22.85	11.34
Burkitt's lymphoma cell line:DAUDI	10422-106C8	32.26	13.71
Burkitt's lymphoma cell line:RAJI	10476-106I8	59.16	23.06
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	49.25	20.15
CD133+ stem cells - cord blood derived, pool1	12223-129E9	41.37	31.03
CD14+ Monocytes, donor1	11224-116B9	13.53	6.20
CD14+ Monocytes, donor2	11305-117B9	9.28	6.50
CD14+ Monocytes, donor3	11381-118B4	10.54	6.15
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	17.83	5.09
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	20.09	9.10
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	19.40	8.55
CD14+ monocytes - mock treated, donor1	11863-125A9	9.11	2.46
CD14+ monocytes - mock treated, donor2	11873-125C1	10.26	3.32
CD14+ monocytes - mock treated, donor3	11883-125D2	8.77	3.55
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	7.87	1.51
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	10.21	2.21
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	12.64	1.24
CD14+ monocytes - treated with BCG, donor1	11860-125A6	6.07	0.78
CD14+ monocytes - treated with BCG, donor2	11870-125B7	5.16	1.07
CD14+ monocytes - treated with BCG, donor3	11880-125C8	8.05	1.96
CD14+ monocytes - treated with Candida, donor1	11868-125B5	4.92	1.64
CD14+ monocytes - treated with Candida, donor2	11878-125C6	12.67	3.70
CD14+ monocytes - treated with Candida, donor3	11888-125D7	5.55	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	3.87	1.93
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	9.18	2.20
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	9.16	4.58
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	5.49	1.37
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	7.46	1.13
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	5.24	0.87
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	2.42	1.61
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	8.03	1.22
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	9.26	3.37
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	4.04	0.73
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	9.16	1.76
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	11.41	2.63
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	5.75	1.74
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	7.43	2.23
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	8.41	3.66
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	3.69	2.87
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	4.87	2.09
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	7.66	2.78
CD14+CD16+ Monocytes, donor1	11789-124B7	14.82	10.24
CD14+CD16+ Monocytes, donor2	11801-124D1	13.86	7.62
CD14+CD16+ Monocytes, donor3	11912-125G4	15.38	6.50
CD14+CD16- Monocytes, donor1	11788-124B6	21.96	10.28
CD14+CD16- Monocytes, donor2	11799-124C8	16.07	9.95
CD14+CD16- Monocytes, donor3	11910-125G2	35.45	19.84
CD14-CD16+ Monocytes, donor1	11790-124B8	13.27	9.44
CD14-CD16+ Monocytes, donor2	11800-124C9	12.52	7.47
CD14-CD16+ Monocytes, donor3	11911-125G3	13.05	5.26
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	46.74	18.29
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	25.09	17.63
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	24.85	18.64
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	32.52	13.33
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	35.92	24.12
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	26.67	18.95
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	26.67	13.33
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	34.28	17.14
CD19+ B Cells, donor1	11544-120B5	43.56	39.45
CD19+ B Cells, donor2	11624-122B4	28.29	26.84
CD19+ B Cells, donor3	11705-123B4	40.39	25.24
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	35.56	19.80
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	23.57	14.38
CD34+ Progenitors, donor1	11545-120B6	40.16	23.09
CD34+ Progenitors, donor2	11625-122B5	26.97	15.73
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	42.46	15.41
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	46.90	18.49
CD4+ T Cells, donor1	11225-116C1	31.42	29.28
CD4+ T Cells, donor2	11306-117C1	15.92	15.31
CD4+ T Cells, donor3	11382-118B5	23.18	20.13
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	35.73	25.78
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	26.95	19.76
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	28.46	19.55
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	38.40	29.39
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	40.03	34.41
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	16.48	32.96
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	16.47	15.90
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	14.74	15.42
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	13.06	12.41
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	18.83	15.69
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	24.46	21.66
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	24.64	17.16
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	30.36	24.88
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	20.15	17.66
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	20.72	18.04
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	33.45	35.62
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	47.70	57.35
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	25.11	34.07
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	32.26	27.81
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	20.15	15.81
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	23.12	16.39
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	27.30	23.76
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	26.86	18.20
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	40.53	29.64
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	32.66	30.19
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	30.47	21.23
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	32.10	26.52
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	44.31	31.57
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	45.40	38.28
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	26.18	24.64
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	34.38	28.65
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	24.93	18.00
CD8+ T Cells, donor1	11226-116C2	42.23	19.64
CD8+ T Cells, donor2	11307-117C2	20.65	18.02
CD8+ T Cells, donor3	11383-118B6	26.51	26.76
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	26.84	12.62
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	28.28	16.30
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	35.02	16.14
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	36.03	21.31
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	26.64	13.68
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	26.15	15.01
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	26.51	12.82
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	30.01	13.69
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	25.56	12.66
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	27.47	17.51
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	26.15	14.23
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	21.31	11.99
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	17.51	10.94
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	21.86	10.02
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	19.39	9.70
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	24.49	17.29
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	23.59	17.26
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	25.69	16.26
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	21.23	17.75
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	19.38	16.30
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	19.24	12.18
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	27.92	21.04
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	21.28	11.82
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	17.40	15.88
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	41.75	31.32
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	48.96	27.98
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	37.06	40.07
Cardiac Myocyte, donor1	11525-119I4	7.31	3.66
Cardiac Myocyte, donor2	11605-120I3	10.38	3.95
Cardiac Myocyte, donor3	11686-122I3	11.15	4.31
Chondrocyte - de diff, donor1	11261-116G1	7.97	5.89
Chondrocyte - de diff, donor2	11338-117F6	3.55	2.84
Chondrocyte - de diff, donor3	11410-118E6	5.58	2.73
Chondrocyte - re diff, donor2	11339-117F7	23.28	17.01
Chondrocyte - re diff, donor3	11411-118E7	8.49	2.02
Ciliary Epithelial Cells, donor1	11242-116D9	22.03	9.75
Ciliary Epithelial Cells, donor2	11323-117D9	13.68	6.63
Ciliary Epithelial Cells, donor3	11399-118D4	16.90	6.19
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	10.00	8.71
Corneal Epithelial Cells, donor1	11526-119I5	3.29	0.66
Corneal Epithelial Cells, donor2	11606-120I4	10.24	7.96
Corneal Epithelial Cells, donor3	11687-122I4	3.58	2.30
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	16.84	9.25
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	12.62	5.99
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	13.80	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	6.37	6.48
Dendritic Cells - plasmacytoid, donor1	11228-116C4	22.89	14.69
Dendritic Cells - plasmacytoid, donor2	11309-117C4	13.71	26.77
Dendritic Cells - plasmacytoid, donor3	11385-118B8	22.75	28.55
Endothelial Cells - Aortic, donor0	11207-116A1	8.84	3.17
Endothelial Cells - Aortic, donor1	11263-116G3	1.76	2.35
Endothelial Cells - Aortic, donor2	11340-117F8	6.50	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	5.90	3.54
Endothelial Cells - Artery, donor1	11264-116G4	3.78	2.91
Endothelial Cells - Artery, donor2	11341-117F9	8.94	2.59
Endothelial Cells - Artery, donor3	11413-118E9	4.56	1.40
Endothelial Cells - Lymphatic, donor1	11236-116D3	10.42	5.32
Endothelial Cells - Lymphatic, donor2	11317-117D3	14.91	6.39
Endothelial Cells - Lymphatic, donor3	11393-118C7	18.61	5.07
Endothelial Cells - Microvascular, donor1	11265-116G5	6.83	2.08
Endothelial Cells - Microvascular, donor2	11342-117G1	5.21	1.56
Endothelial Cells - Microvascular, donor3	11414-118F1	2.55	0.85
Endothelial Cells - Thoracic, donor1	11266-116G6	18.01	4.80
Endothelial Cells - Thoracic, donor2	11343-117G2	2.62	0.52
Endothelial Cells - Umbilical vein, donor1	11243-116E1	28.45	7.70
Endothelial Cells - Umbilical vein, donor2	11324-117E1	16.29	5.00
Endothelial Cells - Umbilical vein, donor3	11400-118D5	15.51	4.15
Endothelial Cells - Vein, donor1	11267-116G7	5.69	0.00
Endothelial Cells - Vein, donor2	11344-117G3	4.89	1.40
Endothelial Cells - Vein, donor3	11416-118F3	3.45	2.20
Eosinophils, donor1	12244-129H3	30.49	0.00
Eosinophils, donor2	12245-129H4	11.55	0.00
Eosinophils, donor3	12246-129H5	3.57	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	4.40	0.49
Esophageal Epithelial Cells, donor2	11587-120G3	2.08	2.08
Esophageal Epithelial Cells, donor3	11668-122G3	16.27	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	7.39	6.16
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	4.49	2.74
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	6.50	5.53
Fibroblast - Aortic Adventitial, donor1	11245-116E3	14.67	5.34
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	28.80	11.33
Fibroblast - Aortic Adventitial, donor2	11326-117E3	7.49	4.85
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	25.30	13.44
Fibroblast - Aortic Adventitial, donor3	11401-118D6	12.62	6.98
Fibroblast - Cardiac, donor1	11268-116G8	6.80	4.54
Fibroblast - Cardiac, donor2	11345-117G4	6.82	2.27
Fibroblast - Cardiac, donor3	11417-118F4	5.52	1.89
Fibroblast - Cardiac, donor4	11452-119A3	27.28	9.09
Fibroblast - Cardiac, donor5	11456-119A7	10.66	6.98
Fibroblast - Cardiac, donor6	11460-119B2	13.95	6.82
Fibroblast - Choroid Plexus, donor1	11492-119E7	7.37	4.82
Fibroblast - Choroid Plexus, donor2	11572-120E6	8.20	5.61
Fibroblast - Choroid Plexus, donor3	11653-122E6	16.11	1.46
Fibroblast - Conjunctival, donor1	11531-120A1	5.07	2.54
Fibroblast - Conjunctival, donor3	11692-122I9	12.04	9.50
Fibroblast - Dermal, donor1	11269-116G9	9.39	5.87
Fibroblast - Dermal, donor2	11346-117G5	8.02	2.83
Fibroblast - Dermal, donor3	11418-118F5	8.70	7.86
Fibroblast - Dermal, donor4	11450-119A1	18.88	10.85
Fibroblast - Dermal, donor5	11454-119A5	17.27	10.64
Fibroblast - Dermal, donor6	11458-119A9	20.95	12.99
Fibroblast - Gingival, donor1	11237-116D4	26.24	14.58
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	9.96	8.65
Fibroblast - Gingival, donor2	11318-117D4	14.23	11.47
Fibroblast - Gingival, donor3	11394-118C8	13.73	12.76
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	11.43	6.23
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	6.70	4.23
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	12.78	8.26
Fibroblast - Gingival, donor6 (control)	11922-125H5	15.15	9.87
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	4.59	3.88
Fibroblast - Gingival, donor7 (control)	11924-125H7	10.38	7.46
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	11.73	7.50
Fibroblast - Gingival, donor8 (control)	11926-125H9	24.57	15.47
Fibroblast - Gingival, donor9 (control)	11927-125I1	11.30	8.22
Fibroblast - Lung, donor1	11270-116H1	8.16	0.00
Fibroblast - Lung, donor2	11347-117G6	5.97	10.45
Fibroblast - Lung, donor3	11419-118F6	6.12	4.22
Fibroblast - Lymphatic, donor1	11506-119G3	3.33	3.33
Fibroblast - Lymphatic, donor2	11586-120G2	6.99	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	0.84	0.56
Fibroblast - Mammary, donor1	11540-120B1	8.12	3.25
Fibroblast - Mammary, donor2	11620-122A9	0.00	3.99
Fibroblast - Mammary, donor3	11701-123A9	5.96	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	12.41	8.34
Fibroblast - Periodontal Ligament, donor2	11319-117D5	18.05	13.95
Fibroblast - Periodontal Ligament, donor3	11395-118C9	26.62	15.30
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	8.40	6.11
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	7.83	5.94
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	5.57	3.48
Fibroblast - Pulmonary Artery, donor1	11250-116E8	9.17	5.53
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	5.89	2.84
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	1.34	1.34
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	6.33	6.33
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	21.04	11.91
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	9.06	5.51
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	11.04	7.29
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	14.74	6.32
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	16.84	10.69
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	13.41	7.59
Fibroblast - skin normal, donor1	11553-120C5	6.07	4.27
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	22.66	13.23
Fibroblast - skin normal, donor2	11561-120D4	11.75	7.64
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	19.04	8.46
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	12.76	8.70
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	20.34	11.45
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	11.17	5.91
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	11.29	6.71
Fibroblast - skin walker warburg, donor1	11554-120C6	7.08	3.20
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	6.43	5.49
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	110.80	88.64
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	18.30	21.79
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	19.59	6.59
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	30.45	5.73
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	38.84	10.73
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	84.98	16.84
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	111.02	28.08
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	151.48	46.50
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	61.77	24.27
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	52.74	27.63
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	89.75	29.32
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	54.98	24.58
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	47.29	26.42
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	133.99	31.40
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	106.98	21.06
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	69.33	16.50
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	62.32	18.54
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	52.78	14.62
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	74.47	16.33
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	71.97	17.48
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	31.72	10.95
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	55.81	12.58
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	50.93	15.96
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	26.30	13.59
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	46.10	14.47
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	42.23	10.50
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	25.00	11.69
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	40.88	15.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	50.99	13.30
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	35.69	17.90
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	32.28	15.37
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	25.78	13.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	36.02	14.14
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	41.45	10.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	21.04	9.70
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	25.48	12.22
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	22.85	13.17
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	14.11	12.78
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	27.67	16.48
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	24.80	12.48
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	17.64	12.19
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	16.11	8.05
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	14.39	9.17
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	16.42	12.47
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	20.18	8.26
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	15.15	12.73
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	17.67	12.06
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	14.17	6.20
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	7.75	9.09
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	14.54	6.89
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	13.60	4.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	12.20	6.51
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	11.61	7.01
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	13.16	7.02
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	9.92	5.95
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	9.89	4.62
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	9.68	4.64
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	21.60	16.27
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	170.79	47.38
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	180.42	40.06
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	183.51	35.19
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	48.82	14.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	43.80	12.43
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	82.56	23.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	59.40	22.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	80.84	27.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	52.95	16.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	60.86	15.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	58.26	19.20
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	73.71	22.24
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	66.65	23.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	51.46	20.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	49.68	17.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	50.33	19.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	41.35	18.45
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	40.76	12.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	35.50	12.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	46.96	20.62
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	16.58	7.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	33.88	8.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	35.62	19.88
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	40.27	21.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	5.27	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	26.14	13.07
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	26.73	11.41
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	19.40	12.04
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	46.23	18.49
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	73.95	23.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	39.76	17.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	47.66	21.71
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	23.54	13.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	32.05	19.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	38.69	25.13
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	41.44	18.75
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	54.30	33.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	36.17	16.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	37.74	25.89
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	44.08	18.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	22.68	11.34
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	19.41	15.04
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	4.57	5.71
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	4.99	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	3.37	4.50
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	8.25	4.76
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	2.92	3.34
Hep-2 cells mock treated, biol_rep1	11898-125E8	12.65	11.02
Hep-2 cells mock treated, biol_rep2	11899-125E9	12.49	10.97
Hep-2 cells mock treated, biol_rep3	11900-125F1	12.74	10.01
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	12.13	8.64
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	15.04	9.03
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	10.55	7.32
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	9.09	8.84
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	8.92	5.83
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	7.69	8.01
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	3.92	1.68
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	2.16	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	18.51	2.64
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	3.53	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	4.36	1.45
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	7.17	3.32
Hepatocyte, donor1	11523-119I2	13.32	14.53
Hepatocyte, donor2	11603-120I1	17.24	11.85
Hepatocyte, donor3	11684-122I1	12.27	18.41
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	46.34	41.77
Intestinal epithelial cells (polarized), donor1	11246-116E4	33.56	11.19
Iris Pigment Epithelial Cells, donor1	11530-119I9	13.17	6.17
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	6.37	6.37
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	20.03	20.03
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	9.69	1.38
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	10.01	2.50
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	11.87
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	2.56	2.56
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	4.57	4.57
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	9.75	6.50
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	6.67	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	0.00	3.63
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	13.23	6.62
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	5.54	4.43
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	5.24	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	8.19	3.15
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	6.46	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	11.27	1.61
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	11.95
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	7.33	3.26
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	2.10	2.94
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	8.84	5.63
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	7.39	4.62
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	8.02	3.30
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	3.63	2.72
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	14.74
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	7.53	3.23
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	7.62	1.27
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	16.43	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	4.46	3.19
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	7.29	3.65
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	5.71	2.14
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	9.95	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	7.10	4.32
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	3.51	7.02
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	12.57	3.14
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	8.34	4.17
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	4.43	6.64
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	6.48	3.24
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	7.85	6.10
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	0.00	3.48
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	4.27	3.20
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	12.47	1.39
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	8.55	14.25
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	7.36	1.84
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	3.03	6.05
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	6.34	4.23
Keratinocyte - epidermal, donor1	11272-116H3	29.95	9.96
Keratinocyte - epidermal, donor2	11349-117G8	4.69	1.17
Keratinocyte - epidermal, donor3	11421-118F8	18.27	10.32
Keratinocyte - oral, donor1	11251-116E9	44.73	21.23
Keratocytes, donor1	11527-119I6	3.09	2.41
Keratocytes, donor2	11607-120I5	3.52	1.17
Keratocytes, donor3	11688-122I5	10.47	7.51
Krukenberg tumor cell line:HSKTC	10687-109F3	6.59	2.20
Lens Epithelial Cells, donor1	11529-119I8	14.02	4.31
Lens Epithelial Cells, donor2	11609-120I7	9.92	6.46
Lens Epithelial Cells, donor3	11690-122I7	14.13	6.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	6.52	2.37
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	3.63	1.67
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	7.87	2.52
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	4.84	2.69
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	1.58	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	3.56	1.29
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	2.46	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	2.53	1.26
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	5.63	1.13
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	8.70	3.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	3.88	1.94
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	1.48	1.11
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	4.88	1.39
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	5.01	1.43
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	4.40	1.37
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	5.54	3.70
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	1.56	0.62
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	2.74	2.38
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	5.27	2.30
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	2.64	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	1.49	1.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	6.30	0.97
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	4.85	2.96
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	4.39	2.57
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	4.15	6.22
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	6.91	3.77
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	4.81	1.95
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	6.88	2.75
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	3.76	2.26
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	2.23	0.95
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	7.27	2.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	3.97	1.32
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	1.98	1.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	9.63	2.59
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	3.46	0.99
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	2.61	0.96
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	4.82	1.29
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	7.91	3.04
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	4.62	1.96
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	7.82	2.49
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	4.36	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	1.87	0.62
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	3.94	2.51
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	5.88	1.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	1.41	1.65
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	7.05	4.95
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	3.33	1.28
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	3.28	2.39
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	11.33	6.80
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	9.97	9.97
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	11.88	2.23
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	10.16	7.19
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	8.44	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	14.94	3.74
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	10.82	5.15
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	17.84	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	12.67	4.98
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	14.25	5.23
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	9.00	4.95
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	18.97	5.55
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	11.81	3.59
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	10.59	4.94
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	15.33	4.66
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	20.38	9.68
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	15.74	6.40
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	19.65	8.88
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	11.66	7.98
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	25.28	7.34
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	15.83	7.08
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	22.42	6.73
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	9.27	6.18
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	15.97	4.06
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	14.95	6.28
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	10.51	4.43
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	18.03	8.13
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	15.49	6.64
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	12.66	3.45
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	13.82	6.14
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	14.72	5.10
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	9.03	6.56
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	14.91	5.87
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	15.08	5.03
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	12.70	5.23
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	8.55	9.66
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	6.03	4.31
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	9.42	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	14.33	6.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	10.26	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	4.98	4.27
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	8.59	6.19
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	14.49	2.15
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	8.75	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	13.33	9.26
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	9.30	4.65
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	12.69	3.17
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	18.41	6.40
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	8.72	7.27
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	7.67	3.83
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	14.80	5.92
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	16.94	7.53
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	19.11	3.02
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	18.93	5.41
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	17.21	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	18.26	10.24
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	19.55	7.82
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	14.51	7.92
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	11.94	6.23
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	22.75	7.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	20.69	5.03
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	13.69	6.62
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	22.37	8.87
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	24.31	9.11
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	21.63	3.84
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	21.07	8.75
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	18.84	6.68
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	21.44	8.30
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	20.14	10.64
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	23.24	10.84
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	12.09	10.28
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	20.60	8.24
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	21.32	7.46
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	24.71	6.90
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	28.28	9.77
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	21.93	9.90
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	21.56	6.81
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	18.72	11.65
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	19.58	10.18
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	17.95	5.43
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	17.19	6.97
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	18.06	10.04
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	21.39	8.02
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	21.82	5.66
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	18.36	2.75
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	16.89	8.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	20.52	9.69
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	17.64	3.07
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	17.51	6.02
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	17.37	8.02
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	16.38	5.72
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	15.91	7.29
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	10.39	4.16
Macrophage - monocyte derived, donor1	11232-116C8	9.57	5.01
Macrophage - monocyte derived, donor2	11313-117C8	9.91	3.49
Macrophage - monocyte derived, donor3	11389-118C3	6.29	3.80
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	12.21	2.66
Mallassez-derived cells, donor2	11929-125I3	27.57	10.46
Mallassez-derived cells, donor3	11930-125I4	33.08	10.70
Mammary Epithelial Cell, donor1	11273-116H4	36.17	17.74
Mammary Epithelial Cell, donor2	11350-117G9	26.35	13.61
Mammary Epithelial Cell, donor3	11422-118F9	4.99	1.50
Mast cell - stimulated, donor1	11487-119E2	355.24	169.48
Mast cell, donor1	11563-120D6	21.09	10.60
Mast cell, donor2	11565-120D8	23.77	13.37
Mast cell, donor3	11566-120D9	30.39	19.81
Mast cell, donor4	11567-120E1	23.93	18.62
Mast cell, expanded and stimulated, donor5	11940-126A5	26.06	20.63
Mast cell, expanded and stimulated, donor8	11942-126A7	15.76	12.26
Mast cell, expanded, donor5	11939-126A4	19.27	9.52
Mast cell, expanded, donor8	11941-126A6	18.08	8.87
Melanocyte - dark, donor1	11502-119F8	8.66	2.49
Melanocyte - dark, donor2	11582-120F7	7.27	3.81
Melanocyte - dark, donor3	11663-122F7	16.37	6.09
Melanocyte - light, donor1	11274-116H5	4.94	1.65
Melanocyte - light, donor2	11351-117H1	5.46	1.36
Melanocyte - light, donor3	11423-118G1	3.47	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	21.76	9.58
Melanocyte, donor2 (MC+2)	12739-135I3	13.72	7.26
Melanocyte, donor3 (MC+3)	12837-137B2	18.48	12.59
Meningeal Cells, donor1	11493-119E8	11.54	5.71
Meningeal Cells, donor2	11573-120E7	6.16	3.96
Meningeal Cells, donor3	11654-122E7	22.82	11.49
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	11.98	4.85
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	8.96	6.74
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	1.31	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	7.18	7.18
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	7.20	5.72
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	5.03	2.51
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	4.61	2.86
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	3.65	2.19
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	1.84	1.23
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	6.23	4.85
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	1.86	0.74
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	15.92	7.11
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	2.97	1.48
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	2.56	0.64
Mesenchymal stem cells - adipose, donor0	11217-116B2	6.38	4.96
Mesenchymal stem cells - hepatic, donor0	11218-116B3	11.57	3.44
Mesenchymal stem cells - umbilical, donor0	11214-116A8	2.90	2.90
Mesothelial Cells, donor1	11247-116E5	11.67	5.83
Mesothelial Cells, donor2	12156-128G5	8.01	5.51
Mesothelial Cells, donor3	11402-118D7	11.06	5.93
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	8.10	1.35
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	9.11	4.68
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	8.24	5.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	7.75	3.10
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	6.85	3.11
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	4.63	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	7.01	4.50
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	3.26	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	5.49	3.66
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	3.17	3.56
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	3.54	2.65
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	3.04	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	1.32	1.32
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	2.12	1.70
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	0.00	0.92
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	1.79	0.89
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	5.03	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	1.51	1.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	3.33	1.90
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	1.66	2.21
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	4.14	1.61
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	5.68	1.89
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	3.47	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	4.93	1.29
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	2.45	1.78
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	2.85	1.75
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	2.03	1.52
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	0.00	3.31
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	3.53	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	2.35	2.94
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	3.27	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	7.69	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	3.60	2.00
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	3.00	1.00
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	3.94	3.50
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	1.10	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	0.64	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	2.98	3.97
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	1.39	2.09
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	3.76	2.74
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	2.19	3.06
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	4.97	1.07
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	3.37	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	1.66	1.25
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	0.00	0.00
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	2.41	0.30
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	2.50	2.09
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	0.00	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	4.55	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	2.90	1.66
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	2.33	0.52
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	3.86	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	2.94	0.80
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	3.29	2.69
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	3.11	0.71
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	1.27	0.64
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	3.98	2.43
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	1.90	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	5.11	0.57
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	5.65	2.70
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	0.65	0.65
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	2.35	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	5.19	1.44
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	4.12	2.06
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	2.38	0.89
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	11.30	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	1.78	1.78
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	6.24	5.26
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	3.16	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	5.73	5.14
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	5.59	5.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	6.76	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	6.13	1.60
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	11.76	4.52
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	5.89	0.74
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	7.69	2.56
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	3.11	9.33
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	3.21	0.53
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	0.00	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	6.81	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	1.91	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	1.62	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	4.53	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	39.97	17.13
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	58.72	19.57
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	4.75	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	37.65	12.55
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	10.13	5.17
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	8.36	6.27
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	8.01	2.67
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	2.92	1.25
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	17.68	17.68
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	9.58	7.98
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	7.48	4.08
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	25.73	18.38
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	3.77	3.77
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	5.11	5.35
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	2.70	6.22
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	9.25	8.41
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	11.13	22.27
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	2.48	3.97
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	8.39	7.58
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	5.21	4.99
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	6.37	3.92
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	13.12	7.47
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	5.30	3.71
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	6.60	4.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	17.07	12.80
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	7.97	2.76
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	12.70	7.41
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	9.14	9.14
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	5.52	3.22
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	9.00	5.46
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	14.14	17.93
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	15.17	32.87
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	9.80	6.46
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	5.93	2.12
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	6.88	5.22
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	10.73	6.01
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	63.19	108.33
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	9.00	3.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	9.02	5.41
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	6.75	2.38
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	6.50	5.57
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	4.16	8.32
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	4.89	6.52
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	6.97	3.05
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	11.31	8.59
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	7.94	7.06
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	10.64	3.32
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	8.43	5.46
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	4.98	6.51
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	5.75	8.77
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	9.28	8.18
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	6.78	7.45
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	35.77	30.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	7.93	3.66
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	2.83	3.46
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	6.05	4.54
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	7.91	3.96
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	17.00	19.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	20.23	30.35
Myoblast, donor1	11241-116D8	11.43	8.32
Myoblast, donor2	11322-117D8	10.93	9.01
Myoblast, donor3	11398-118D3	14.46	6.73
NK T cell leukemia cell line:KHYG-1	10777-110G3	34.44	12.84
Natural Killer Cells, donor1	11230-116C6	39.05	22.76
Natural Killer Cells, donor2	11311-117C6	20.20	16.89
Natural Killer Cells, donor3	11387-118C1	23.74	16.56
Neural stem cells, donor1	11275-116H6	55.89	26.13
Neural stem cells, donor2	11352-117H2	80.88	65.47
Neurons, donor1	11494-119E9	34.14	22.76
Neurons, donor2	11574-120E8	19.81	15.19
Neurons, donor3	11655-122E8	44.40	32.89
Neutrophils, donor1	11233-116C9	0.93	0.00
Neutrophils, donor2	11314-117C9	2.90	0.00
Neutrophils, donor3	11390-118C4	1.22	2.44
Nucleus Pulposus Cell, donor1	11252-116F1	19.71	16.50
Nucleus Pulposus Cell, donor2	11409-118E5	4.88	2.60
Nucleus Pulposus Cell, donor3	11462-119B4	9.63	6.42
Olfactory epithelial cells, donor1	11933-125I7	10.19	7.85
Olfactory epithelial cells, donor2	11934-125I8	10.42	8.11
Olfactory epithelial cells, donor3	11935-125I9	9.65	8.63
Olfactory epithelial cells, donor4	11936-126A1	12.37	9.93
Oligodendrocyte - precursors, donor1	11496-119F2	13.84	4.21
Osteoblast - differentiated, donor1	11276-116H7	4.47	5.10
Osteoblast - differentiated, donor2	11353-117H3	3.43	2.29
Osteoblast - differentiated, donor3	11425-118G3	4.34	2.48
Osteoblast, donor1	11277-116H8	2.54	2.15
Osteoblast, donor2	11354-117H4	15.45	3.51
Osteoblast, donor3	11426-118G4	6.58	3.91
Pancreatic stromal cells, donor1	11249-116E7	13.14	8.17
Pericytes, donor1	11491-119E6	2.00	1.11
Pericytes, donor2	11571-120E5	2.26	1.81
Pericytes, donor3	11652-122E5	4.27	1.22
Perineurial Cells, donor1	11499-119F5	12.09	4.07
Perineurial Cells, donor2	11579-120F4	13.62	5.70
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	29.32	19.44
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	13.96	13.71
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	12.55	12.55
Placental Epithelial Cells, donor1	11278-116H9	3.83	1.43
Placental Epithelial Cells, donor2	11355-117H5	0.00	3.33
Placental Epithelial Cells, donor3	11427-118G5	2.16	1.57
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	3.16	2.22
Preadipocyte - breast, donor1	11467-119B9	6.57	4.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	10.70	5.35
Preadipocyte - breast, donor2	11328-117E5	2.93	3.15
Preadipocyte - omental, donor1	11468-119C1	5.54	4.58
Preadipocyte - omental, donor2	11329-117E6	5.24	4.36
Preadipocyte - omental, donor3	11403-118D8	7.45	2.29
Preadipocyte - perirenal, donor1	11469-119C2	0.98	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	5.53	3.07
Preadipocyte - subcutaneous, donor2	11356-117H6	15.58	10.80
Preadipocyte - subcutaneous, donor3	11428-118G6	9.54	6.64
Preadipocyte - visceral, donor1	11280-116I2	18.26	10.90
Preadipocyte - visceral, donor2	11357-117H7	12.42	11.96
Preadipocyte - visceral, donor3	11429-118G7	11.18	6.48
Prostate Epithelial Cells (polarized), donor1	11253-116F2	44.50	9.50
Prostate Epithelial Cells, donor2	11331-117E8	15.71	6.09
Prostate Epithelial Cells, donor3	11404-118D9	17.58	11.08
Prostate Stromal Cells, donor1	11254-116F3	9.34	6.38
Prostate Stromal Cells, donor2	11332-117E9	6.10	5.74
Prostate Stromal Cells, donor3	11405-118E1	5.01	4.28
Renal Cortical Epithelial Cells, donor1	11516-119H4	4.01	1.46
Renal Cortical Epithelial Cells, donor2	11596-120H3	15.04	7.62
Renal Epithelial Cells, donor1	11517-119H5	2.54	1.01
Renal Epithelial Cells, donor2	11597-120H4	1.42	2.13
Renal Epithelial Cells, donor3	11678-122H4	19.58	8.89
Renal Glomerular Endothelial Cells, donor1	11514-119H2	1.36	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	3.91	0.81
Renal Glomerular Endothelial Cells, donor3	11675-122H1	12.21	4.88
Renal Glomerular Endothelial Cells, donor4	11783-124B1	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	2.64	0.88
Renal Mesangial Cells, donor2	11598-120H5	0.63	2.51
Renal Mesangial Cells, donor3	11679-122H5	1.94	1.11
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	8.59	2.15
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	2.95	2.53
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	2.89	2.31
Retinal Pigment Epithelial Cells, donor0	11215-116A9	10.89	5.96
Retinal Pigment Epithelial Cells, donor1	11528-119I7	9.38	2.84
Retinal Pigment Epithelial Cells, donor2	11608-120I6	1.03	1.03
Retinal Pigment Epithelial Cells, donor3	11689-122I6	16.06	12.55
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	21.25	12.03
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	27.70	11.61
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	60.54	30.27
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	49.88	20.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	37.97	20.80
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	20.95	10.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	33.80	14.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	47.38	16.87
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	25.52	13.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	43.68	19.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	26.01	9.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	26.32	15.43
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	24.73	9.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	24.53	9.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	30.48	11.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	23.68	14.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	26.96	9.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	22.92	12.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	39.65	13.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	30.39	11.68
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	30.08	14.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	35.14	10.31
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	27.98	11.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	19.62	15.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	24.95	16.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	26.62	10.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	22.93	11.77
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	28.34	15.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	33.73	12.50
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	25.60	12.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	26.89	15.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	28.82	10.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	28.54	25.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	26.95	11.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	22.21	9.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	20.44	10.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	28.73	14.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	31.12	10.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	18.11	10.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	27.58	14.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	20.79	10.74
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	25.00	9.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	26.92	8.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	28.62	9.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	18.57	8.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	34.67	12.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	21.66	8.29
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	27.25	9.78
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	23.57	7.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	24.60	8.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	75.54	20.52
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	27.38	15.21
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	22.91	8.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	23.75	7.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	38.94	14.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	33.42	14.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	22.84	10.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	30.65	13.82
Schwann Cells, donor1	11498-119F4	3.20	1.32
Schwann Cells, donor2	11578-120F3	0.00	3.40
Schwann Cells, donor3	11659-122F3	7.01	4.16
Sebocyte, donor1	11220-116B5	33.41	7.12
Sebocyte, donor2	11301-117B5	20.68	10.57
Sebocyte, donor3	11378-118B1	8.24	5.15
Sertoli Cells, donor1	11255-116F4	4.97	3.31
Sertoli Cells, donor2	11333-117F1	11.30	5.65
Skeletal Muscle Cells, donor1	11281-116I3	13.11	7.21
Skeletal Muscle Cells, donor2	11358-117H8	0.72	2.17
Skeletal Muscle Cells, donor3	11430-118G8	6.69	4.18
Skeletal Muscle Cells, donor4	11451-119A2	14.30	6.44
Skeletal Muscle Cells, donor5	11455-119A6	16.95	8.92
Skeletal Muscle Cells, donor6	11459-119B1	22.01	12.16
Skeletal Muscle Satellite Cells, donor1	11240-116D7	20.16	7.18
Skeletal Muscle Satellite Cells, donor2	11321-117D7	10.27	5.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	12.30	6.94
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	17.52	7.41
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	3.62	4.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	2.61	3.44
Skin - palm, donor1	10286-104F7	21.49	5.37
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	8.94	4.04
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	183.21	24.54
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	12.33	4.80
Small Airway Epithelial Cells, donor1	11256-116F5	23.77	8.48
Small Airway Epithelial Cells, donor2	11334-117F2	23.07	8.58
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	131.52	25.58
Small Airway Epithelial Cells, donor3	11406-118E2	13.34	7.79
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	4.63	3.39
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	11.12	6.00
Smooth Muscle Cells - Aortic, donor0	11210-116A4	5.29	2.94
Smooth Muscle Cells - Aortic, donor1	11283-116I5	4.20	2.43
Smooth Muscle Cells - Aortic, donor2	11360-117I1	2.36	1.58
Smooth Muscle Cells - Aortic, donor3	11432-118H1	5.41	5.41
Smooth Muscle Cells - Bladder, donor1	11519-119H7	7.01	6.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	3.86	1.46
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	7.09	5.98
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	9.86	9.35
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	13.35	2.60
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	12.40	5.32
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	6.98	2.99
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	1.79	1.95
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	7.00	8.83
Smooth Muscle Cells - Carotid, donor1	11285-116I7	3.79	2.02
Smooth Muscle Cells - Carotid, donor2	11362-117I3	0.00	6.12
Smooth Muscle Cells - Carotid, donor3	11434-118H3	3.34	1.91
Smooth Muscle Cells - Colonic, donor1	11239-116D6	9.88	3.83
Smooth Muscle Cells - Colonic, donor2	11320-117D6	8.39	3.44
Smooth Muscle Cells - Colonic, donor3	11396-118D1	7.24	3.25
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	4.95	2.32
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	5.39	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	2.69	2.69
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	3.07	0.68
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	10.05	5.97
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	16.61	9.86
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	11.83	7.96
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	3.02	3.02
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	20.40	11.13
Smooth Muscle Cells - Prostate, donor1	11257-116F6	7.59	6.66
Smooth Muscle Cells - Prostate, donor2	11335-117F3	7.89	6.01
Smooth Muscle Cells - Prostate, donor3	11465-119B7	2.54	2.79
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	10.10	4.67
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	0.00	5.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	3.88	1.29
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	5.12	3.72
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	8.58	4.04
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	5.33	4.07
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	1.77	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	16.99	6.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	6.54	6.07
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	6.33	2.30
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	3.31	4.59
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	3.01	1.88
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	12.72	7.13
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	8.88	3.94
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	0.48	0.95
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	4.89	2.69
Smooth Muscle Cells - Uterine, donor1	11258-116F7	18.78	7.95
Smooth Muscle Cells - Uterine, donor3	11466-119B8	5.56	7.31
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	8.55	2.92
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	8.73	6.08
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	9.67	6.70
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	14.37	5.03
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	9.94	4.54
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	14.57	5.51
Smooth muscle cells - airway, control, donor1	11966-126D4	9.90	6.35
Smooth muscle cells - airway, control, donor2	11967-126D5	5.99	3.99
Smooth muscle cells - airway, control, donor3	11968-126D6	5.85	2.51
Smooth muscle cells - airway, control, donor4	11969-126D7	5.50	3.21
Synoviocyte, donor1	11291-117A4	15.65	8.75
Synoviocyte, donor2	11368-117I9	5.36	4.02
Synoviocyte, donor3	11440-118H9	4.24	2.90
Trabecular Meshwork Cells, donor1	11532-120A2	5.36	2.14
Trabecular Meshwork Cells, donor2	11612-122A1	7.93	3.96
Trabecular Meshwork Cells, donor3	11693-123A1	2.55	2.08
Tracheal Epithelial Cells, donor1	11292-117A5	11.33	5.95
Tracheal Epithelial Cells, donor2	11369-118A1	9.28	3.09
Tracheal Epithelial Cells, donor3	11441-118I1	7.44	3.44
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	25.84	13.16
Urethra, donor2	10319-105A4	23.38	14.39
Urothelial Cells, donor1	11520-119H8	5.58	1.33
Urothelial Cells, donor2	11600-120H7	8.01	2.40
Urothelial Cells, donor3	11681-122H7	2.75	2.52
Urothelial cells, donor0	11216-116B1	26.97	13.37
Whole blood (ribopure), donor090309, donation1	12179-129A1	13.35	13.35
Whole blood (ribopure), donor090309, donation2	12180-129A2	15.73	12.87
Whole blood (ribopure), donor090309, donation3	12181-129A3	6.85	8.90
Whole blood (ribopure), donor090325, donation1	12176-128I7	18.59	9.99
Whole blood (ribopure), donor090325, donation2	12177-128I8	19.17	11.62
Whole blood (ribopure), donor090612, donation1	12182-129A4	10.41	8.33
Whole blood (ribopure), donor090612, donation2	12183-129A5	22.03	12.85
Whole blood (ribopure), donor090612, donation3	12184-129A6	12.78	10.04
Wilms' tumor cell line:G-401	10809-111A8	25.91	18.01
Wilms' tumor cell line:HFWT	10597-108E3	17.60	16.72
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	79.05	23.74
achilles tendon, donor2	10292-104G4	6.20	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	49.97	13.00
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	72.21	21.59
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	91.17	51.76
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	55.78	31.57
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	67.18	21.08
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	46.53	22.63
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	59.61	26.13
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	55.96	25.56
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	80.45	35.94
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	41.16	27.57
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	47.10	20.24
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	78.01	66.31
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	72.50	37.41
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	84.66	49.45
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	40.33	17.53
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	41.36	18.13
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	39.07	17.68
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	12.58	12.58
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	43.10	21.34
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	39.12	15.77
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	50.07	18.78
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	24.06	18.71
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	53.03	25.02
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	11.15	9.29
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	30.51	4.90
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	44.05	17.45
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	155.58	24.37
adenocarcinoma cell line:IM95m	10796-110I4	28.97	24.49
adipose tissue, adult, pool1	10010-101C1	22.80	11.79
adipose, donor1	10184-103D4	103.21	66.85
adipose, donor2	10185-103D5	25.95	22.71
adipose, donor3	10186-103D6	41.39	25.05
adipose, donor4	10187-103D7	68.47	19.94
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	40.24	18.94
adrenal gland, adult, pool1	10081-102A9	3.64	3.64
adult T-cell leukemia cell line:ATN-1	10421-106C7	56.56	26.81
alveolar cell carcinoma cell line:SW 1573	10708-109H6	23.94	18.94
amniotic membrane cells, donor1	12235-129G3	18.32	9.74
amniotic membrane cells, donor2	12236-129G4	11.83	9.47
amniotic membrane cells, donor3	12237-129G5	17.09	16.79
amygdala - adult, donor10196	10167-103B5	17.79	18.97
amygdala, adult, donor10252	10151-102I7	27.98	18.25
amygdala, newborn, donor10223	10360-105E9	24.53	13.88
anaplastic carcinoma cell line:8305C	10428-106D5	34.63	15.79
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	46.33	20.08
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	64.14	23.05
aorta, adult, pool1	10052-101G7	13.93	9.22
appendix, adult	10189-103D9	29.11	19.02
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	46.78	26.83
artery, adult	10190-103E1	12.23	6.79
astrocytoma cell line:TM-31	10425-106D2	18.69	9.13
b cell line:RPMI1788	10427-106D4	30.78	18.29
basal cell carcinoma cell line:TE 354.T	10702-109G9	8.05	6.94
bile duct carcinoma cell line:HuCCT1	10432-106D9	43.27	21.43
bile duct carcinoma cell line:TFK-1	10496-107C1	31.80	20.25
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	43.06	20.69
bladder, adult, pool1	10011-101C2	28.36	19.56
blood, adult, pool1	10053-101G8	6.64	6.64
bone marrow stromal cell line:StromaNKtert	10686-109F2	10.28	5.14
bone marrow, adult	10192-103E3	16.20	12.15
brain, adult, donor1	10084-102B3	6.15	9.23
brain, adult, pool1	10012-101C3	16.04	13.92
brain, fetal, pool1	10085-102B4	10.69	5.34
breast carcinoma cell line:MCF7	10482-107A5	22.13	14.87
breast carcinoma cell line:MDA-MB-453	10419-106C5	45.56	21.59
breast, adult, donor1	10080-102A8	8.84	8.84
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	18.04	25.92
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	33.09	16.39
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	57.09	28.55
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	13.80	12.59
carcinoid cell line:NCI-H1770	10703-109H1	31.03	17.40
carcinoid cell line:NCI-H727	10735-110B6	43.64	18.70
carcinoid cell line:SK-PN-DW	10719-109I8	55.77	24.40
carcinosarcoma cell line:JHUCS-1	10642-109A3	36.20	38.60
caudate nucleus - adult, donor10196	10177-103C6	28.78	21.88
caudate nucleus, adult, donor10252	10164-103B2	18.24	14.72
caudate nucleus, adult, donor10258	10379-105H1	12.23	16.81
caudate nucleus, newborn, donor10223	10354-105E3	25.64	21.24
cerebellum - adult, donor10196	10173-103C2	61.18	55.35
cerebellum, adult, donor10252	10166-103B4	59.14	33.95
cerebellum, adult, pool1	10083-102B2	18.97	19.32
cerebellum, newborn, donor10223	10357-105E6	43.17	34.87
cerebral meninges, adult	10188-103D8	12.35	12.35
cerebrospinal fluid, donor2	10294-104G6	7.31	5.12
cervical cancer cell line:D98-AH2	10552-107I3	33.21	28.04
cervical cancer cell line:ME-180	10553-107I4	36.62	20.05
cervix, adult, pool1	10013-101C4	25.51	18.06
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	23.83	10.31
chondrosarcoma cell line:SW 1353	10700-109G7	9.14	2.61
choriocarcinoma cell line:BeWo	10423-106C9	45.73	17.77
choriocarcinoma cell line:SCH	10785-110H2	24.27	10.10
choriocarcinoma cell line:T3M-3	10618-108G6	14.71	9.01
chorionic membrane cells, donor1	12238-129G6	15.10	3.70
chorionic membrane cells, donor2	12239-129G7	13.92	5.97
chorionic membrane cells, donor3	12240-129G8	24.18	10.44
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	11.11	20.20
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	31.50	11.33
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	61.88	16.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	52.39	27.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	62.16	30.72
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	72.49	38.48
chronic myelogenous leukemia cell line:K562	10454-106G4	103.06	40.63
chronic myelogenous leukemia cell line:KU812	10409-106B4	147.51	38.83
clear cell carcinoma cell line:JHOC-5	10638-108I8	19.20	11.66
clear cell carcinoma cell line:TEN	10636-108I6	36.44	19.09
colon carcinoma cell line:CACO-2	10513-107D9	35.51	8.60
colon carcinoma cell line:COLO-320	10420-106C6	90.08	58.53
colon, adult, donor1	10082-102B1	10.71	11.90
colon, adult, pool1	10014-101C5	21.15	13.28
colon, fetal, donor1	10070-101I7	22.87	19.78
common myeloid progenitor CMP, donor1	12130-128D6	82.50	22.92
common myeloid progenitor CMP, donor2	12134-128E1	50.07	25.04
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	129.60	57.79
cord blood derived cell line:COBL-a 24h infection	10453-106G3	74.26	28.07
cord blood derived cell line:COBL-a untreated	10449-106F8	88.98	28.63
corpus callosum, adult, pool1	10042-101F6	19.79	11.50
cruciate ligament, donor2	10295-104G7	16.21	8.92
diaphragm, fetal, donor1	10069-101I6	12.84	5.62
diencephalon, adult	10193-103E4	11.28	10.32
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	45.23	20.44
ductal cell carcinoma cell line:KLM-1	10438-106E6	41.80	16.67
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	48.14	13.48
ductus deferens, adult	10196-103E7	20.93	23.42
duodenum, fetal, donor1, tech_rep1	10071-101I8	15.84	20.16
duodenum, fetal, donor1, tech_rep2	10071-101I8	22.81	22.81
dura mater, adult, donor1	10041-101F5	18.33	17.18
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	119.25	53.52
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	49.01	26.51
embryonic pancreas cell line:1B2C6	10604-108F1	16.65	9.87
embryonic pancreas cell line:1C3D3	10605-108F2	20.58	16.04
embryonic pancreas cell line:1C3IKEI	10606-108F3	16.98	17.91
embryonic pancreas cell line:2C6	10603-108E9	26.27	9.19
endometrial carcinoma cell line:OMC-2	10497-107C2	41.23	15.42
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	36.97	21.02
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	26.05	13.99
epidermoid carcinoma cell line:A431	10426-106D3	43.13	15.90
epidermoid carcinoma cell line:Ca Ski	10431-106D8	46.63	21.89
epididymis, adult	10197-103E8	16.33	17.37
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	23.42	14.73
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	19.66	11.80
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	31.98	31.06
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	33.56	37.40
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	23.41	21.40
esophagus, adult, pool1	10015-101C6	21.02	18.90
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	94.43	44.58
eye - muscle inferior rectus, donor1	10272-104E2	19.32	16.90
eye - muscle lateral, donor2	10298-104H1	10.52	12.63
eye - muscle medial, donor2	10299-104H2	10.42	7.44
eye - muscle superior, donor2	10297-104G9	9.17	12.61
eye - vitreous humor, donor1	10268-104D7	8.74	1.46
eye, fetal, donor1	10054-101G9	12.46	10.93
fibrosarcoma cell line:HT-1080	10758-110E2	27.95	13.85
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	15.43	14.48
frontal lobe, adult, pool1	10040-101F4	23.17	10.70
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	50.44	24.62
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	44.35	25.42
gall bladder, adult	10198-103E9	12.31	11.83
gamma delta positive T cells, donor1	11937-126A2	34.90	18.79
gamma delta positive T cells, donor2	11938-126A3	28.01	18.30
gastric adenocarcinoma cell line:MKN1	10614-108G2	33.37	24.50
gastric adenocarcinoma cell line:MKN45	10612-108F9	39.46	31.14
gastric cancer cell line:AZ521	10549-107H9	75.58	29.02
gastric cancer cell line:GSS	10560-108A2	25.63	15.56
gastrointestinal carcinoma cell line:ECC12	10615-108G3	42.72	9.60
giant cell carcinoma cell line:LU65	10487-107B1	33.96	33.73
giant cell carcinoma cell line:Lu99B	10433-106E1	45.21	27.43
glassy cell carcinoma cell line:HOKUG	10688-109F4	11.47	9.73
glioblastoma cell line:A172, tech_rep1	10444-106F3	21.43	16.57
glioblastoma cell line:A172, tech_rep2	10444-106F3	22.75	15.87
glioblastoma cell line:T98G	10485-107A8	19.54	15.01
glioma cell line:GI-1	10413-106B8	30.17	17.57
globus pallidus - adult, donor10196	10175-103C4	22.60	15.31
globus pallidus, adult, donor10252	10161-103A8	47.11	21.48
globus pallidus, adult, donor10258	10367-105F7	13.69	15.06
globus pallidus, newborn, donor10223	10364-105F4	19.19	10.13
granulocyte macrophage progenitor, donor1	12131-128D7	75.86	29.37
granulocyte macrophage progenitor, donor2	12135-128E2	0.00	10.93
granulocyte macrophage progenitor, donor3	12139-128E6	15.68	10.45
granulosa cell tumor cell line:KGN	10624-108H3	11.20	11.20
hIPS +CCl2, biol_rep1	14383-156B9	123.50	21.12
hIPS +CCl2, biol_rep2	14384-156C1	135.81	18.29
hIPS +CCl2, biol_rep3	14385-156C2	106.92	16.75
hIPS, biol_rep1	14380-156B6	61.80	17.25
hIPS, biol_rep2	14381-156B7	89.85	11.66
hIPS, biol_rep3	14382-156B8	20.97	7.72
hairy cell leukemia cell line:Mo	10712-109I1	27.87	11.49
heart - mitral valve, adult	10205-103F7	24.22	16.14
heart - pulmonic valve, adult	10206-103F8	19.87	12.81
heart - tricuspid valve, adult	10207-103F9	44.13	28.31
heart, adult, diseased post-infarction, donor1	10050-101G5	9.59	3.88
heart, adult, diseased, donor1	10051-101G6	7.24	8.94
heart, adult, pool1	10016-101C7	12.19	11.73
heart, fetal, pool1	10046-101G1	33.37	14.48
hepatic mesenchymal tumor cell line:LI90	10778-110G4	10.80	6.17
hepatoblastoma cell line:HuH-6	10633-108I3	42.81	16.65
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	47.51	14.59
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	54.13	16.02
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	58.11	15.56
hepatoma cell line:Li-7	10484-107A7	14.90	11.01
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	29.45	9.45
hippocampus - adult, donor10196	10169-103B7	22.71	18.93
hippocampus, adult, donor10252	10153-102I9	32.04	19.80
hippocampus, adult, donor10258	10374-105G5	13.44	6.97
hippocampus, newborn, donor10223	10363-105F3	23.26	12.34
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	152.59	53.10
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	93.86	28.28
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	125.68	35.55
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	48.49	23.68
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	64.55	33.83
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	67.95	26.57
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	70.36	37.95
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.86	33.18
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	55.89	33.37
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	48.78	22.26
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	46.29	29.73
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	53.86	24.91
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	122.06	35.52
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	143.95	44.71
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	200.73	68.95
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	68.16	36.46
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	58.87	30.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	69.47	46.98
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	36.92	34.48
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	41.38	39.11
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	41.03	32.26
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	33.48	22.37
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	30.77	19.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	32.28	23.32
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	109.37	28.08
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	92.15	26.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	148.63	40.83
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	71.82	30.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	48.46	18.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	49.02	20.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	45.51	25.34
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	40.51	21.92
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	40.79	22.06
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	36.56	21.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	33.32	24.99
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	37.64	19.16
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	115.20	24.39
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	130.58	26.74
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	115.12	28.78
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	60.82	22.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	527.03	305.80
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	92.99	40.37
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	51.45	31.20
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	50.30	24.97
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	50.53	29.54
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	36.99	17.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	54.17	26.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	33.14	19.40
immature langerhans cells, donor1	11904-125F5	61.51	27.60
immature langerhans cells, donor2	11905-125F6	35.65	14.26
insula, adult, pool1	10039-101F3	20.54	9.18
keratoacanthoma cell line:HKA-1	10791-110H8	9.43	6.18
kidney, adult, pool1	10017-101C8	14.62	12.82
kidney, fetal, pool1	10045-101F9	11.95	7.85
large cell lung carcinoma cell line:IA-LM	10509-107D5	65.19	20.02
large cell lung carcinoma cell line:NCI-H460	10839-111E2	12.86	11.34
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	23.85	14.13
left atrium, adult, donor1	10079-102A7	5.99	8.72
left ventricle, adult, donor1	10078-102A6	5.06	3.54
leiomyoblastoma cell line:G-402	10721-110A1	29.82	14.77
leiomyoma cell line:10964C	10569-108B2	4.67	3.59
leiomyoma cell line:15242A	10570-108B3	3.80	1.63
leiomyoma cell line:15425	10571-108B4	4.61	7.28
leiomyosarcoma cell line:Hs 5.T	10722-110A2	6.35	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	17.77	15.68
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	123.25	27.74
liposarcoma cell line:KMLS-1	10782-110G8	10.00	8.44
liposarcoma cell line:SW 872	10726-110A6	13.40	7.31
liver, adult, pool1	10018-101C9	10.53	6.97
liver, fetal, pool1	10086-102B5	1.88	3.76
locus coeruleus - adult, donor10196	10182-103D2	30.48	17.21
locus coeruleus, adult, donor10252	10165-103B3	29.53	14.39
locus coeruleus, adult, donor10258	10375-105G6	14.95	7.62
locus coeruleus, newborn, donor10223	10362-105F2	31.13	26.92
lung adenocarcinoma cell line:A549	10499-107C4	9.96	8.86
lung adenocarcinoma cell line:PC-14	10408-106B3	15.86	16.55
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	33.61	12.65
lung, adult, pool1	10019-101D1	19.25	10.28
lung, fetal, donor1	10068-101I5	62.79	45.95
lung, right lower lobe, adult, donor1	10075-102A3	15.12	13.29
lymph node, adult, donor1	10077-102A5	16.57	17.04
lymphangiectasia cell line:DS-1	10727-110A7	33.32	15.34
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	41.05	23.24
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	110.43	69.66
mature adipocyte, donor1	12231-129F8	6.66	7.10
mature adipocyte, donor2	12232-129F9	11.83	7.68
mature adipocyte, donor3	12233-129G1	6.16	6.40
mature adipocyte, donor4	12234-129G2	11.06	10.00
maxillary sinus tumor cell line:HSQ-89	10414-106B9	44.55	45.51
medial frontal gyrus - adult, donor10196	10170-103B8	21.43	16.92
medial frontal gyrus, adult, donor10252	10150-102I6	30.16	16.74
medial frontal gyrus, adult, donor10258	10368-105F8	10.17	8.58
medial frontal gyrus, newborn, donor10223	10352-105E1	37.53	30.71
medial temporal gyrus - adult, donor10196	10183-103D3	27.84	32.23
medial temporal gyrus, adult, donor10252	10156-103A3	36.93	19.52
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	7.71	7.71
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	14.35	114.83
medial temporal gyrus, newborn, donor10223	10353-105E2	35.18	15.79
medulla oblongata - adult, donor10196	10174-103C3	17.52	14.93
medulla oblongata, adult, donor10252	10155-103A2	30.65	21.36
medulla oblongata, adult, pool1	10038-101F2	16.00	9.14
medulla oblongata, newborn, donor10223	10361-105F1	17.36	10.42
medulloblastoma cell line:D283 Med	10838-111E1	175.36	86.35
medulloblastoma cell line:ONS-76	10759-110E3	42.55	13.21
melanoma cell line:COLO 679	10514-107E1	26.16	12.79
melanoma cell line:G-361	10465-106H6	51.58	38.00
meningioma cell line:HKBMM	10691-109F7	10.85	10.85
merkel cell carcinoma cell line:MKL-1	10843-111E6	96.93	59.04
merkel cell carcinoma cell line:MS-1	10844-111E7	107.58	47.70
mesenchymal precursor cell - adipose, donor1	11747-123G1	11.35	7.06
mesenchymal precursor cell - adipose, donor2	11748-123G2	10.00	6.54
mesenchymal precursor cell - adipose, donor3	11749-123G3	5.80	5.38
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	7.87	5.90
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	8.86	3.85
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	6.94	5.55
mesenchymal precursor cell - cardiac, donor1	11752-123G6	7.21	4.63
mesenchymal precursor cell - cardiac, donor2	11753-123G7	11.16	5.52
mesenchymal precursor cell - cardiac, donor3	11754-123G8	8.89	3.85
mesenchymal precursor cell - cardiac, donor4	11755-123G9	11.88	6.35
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	14.65	6.97
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	8.89	6.92
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	13.98	8.16
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	10.12	6.63
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	8.17	5.10
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	7.91	4.67
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	8.69	4.55
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	7.75	5.47
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	19.72	12.59
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	6.72	4.78
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	10.50	4.99
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	5.89	4.79
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	6.87	4.86
mesenchymal stem cell line:Hu5/E18	10568-108B1	10.10	5.05
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	4.11	3.20
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	8.44	4.60
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	8.90	2.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	7.39	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	7.77	3.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	8.46	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	3.14	2.36
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	7.41	3.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	4.90	4.04
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	5.13	4.24
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	6.25	3.12
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	5.87	9.53
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	6.04	3.02
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	4.50	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	6.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	10.94	2.73
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	0.00	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	6.17	3.57
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	2.91	1.45
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	3.73	5.33
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	5.72	4.09
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	5.44	3.50
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	4.20	4.20
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	3.97	3.97
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	9.53	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	7.71	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	3.66	6.09
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	5.07	5.07
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	6.90	6.21
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	6.45	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	11.98	7.98
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	4.07	2.04
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	5.56	2.38
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	5.90	4.13
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	9.66	3.43
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	6.68	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	8.28	3.55
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	12.84	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	8.26	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	8.41	8.41
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	5.61	4.49
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	4.45	3.82
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	4.84	1.61
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	6.54	4.36
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	1.27	6.34
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	3.03	3.03
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	4.52	4.52
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	5.77	6.59
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	5.56	3.57
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	4.22	4.22
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	4.07	2.04
mesodermal tumor cell line:HIRS-BM	10696-109G3	10.06	5.42
mesothelioma cell line:ACC-MESO-1	10493-107B7	39.45	26.93
mesothelioma cell line:ACC-MESO-4	10494-107B8	43.55	24.09
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	17.09	4.27
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	14.08	5.14
mesothelioma cell line:Mero-25	10850-111F4	19.06	10.44
mesothelioma cell line:Mero-41	10851-111F5	21.02	13.45
mesothelioma cell line:Mero-48a	10852-111F6	15.28	4.43
mesothelioma cell line:Mero-82	10853-111F7	57.29	10.25
mesothelioma cell line:Mero-83	10854-111F8	26.21	13.79
mesothelioma cell line:Mero-84	10855-111F9	12.89	5.81
mesothelioma cell line:Mero-95	10856-111G1	15.32	6.83
mesothelioma cell line:NCI-H2052	10847-111F1	20.87	9.11
mesothelioma cell line:NCI-H226	10846-111E9	23.53	12.13
mesothelioma cell line:NCI-H2452	10848-111F2	15.72	10.93
mesothelioma cell line:NCI-H28	10845-111E8	39.95	35.37
mesothelioma cell line:No36	10857-111G2	15.66	13.70
mesothelioma cell line:ONE58	10858-111G3	11.92	6.23
migratory langerhans cells, donor1	11901-125F2	18.23	16.89
migratory langerhans cells, donor2	11902-125F3	13.92	9.89
migratory langerhans cells, donor3	11903-125F4	24.95	10.77
mixed mullerian tumor cell line:HTMMT	10689-109F5	16.65	7.84
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	3.39	1.91
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	26.49	10.60
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	9.90	9.51
myelodysplastic syndrome cell line:SKM-1	10772-110F7	55.07	29.38
myeloma cell line:PCM6	10474-106I6	22.14	6.52
myxofibrosarcoma cell line:MFH-ino	10600-108E6	24.86	8.12
myxofibrosarcoma cell line:NMFH-1	10684-109E9	25.69	12.75
nasal epithelial cells, donor1, tech_rep1	12226-129F3	17.83	9.58
nasal epithelial cells, donor1, tech_rep2	12226-129F3	23.02	10.37
nasal epithelial cells, donor2	12227-129F4	12.70	5.52
neuroblastoma cell line:CHP-134	10508-107D4	135.74	54.75
neuroblastoma cell line:NB-1	10539-107G8	83.25	41.72
neuroblastoma cell line:NBsusSR	10607-108F4	32.90	14.13
neuroblastoma cell line:NH-12	10555-107I6	175.92	54.60
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	26.33	32.03
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	31.83	29.30
neuroectodermal tumor cell line:TASK1	10774-110F9	33.01	14.29
neuroepithelioma cell line:SK-N-MC	10728-110A8	14.62	16.53
neurofibroma cell line:Hs 53.T	10729-110A9	10.11	4.26
neutrophil PMN, donor1	12133-128D9	0.00	0.00
neutrophil PMN, donor2	12137-128E4	0.00	0.00
neutrophil PMN, donor3	12141-128E8	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	142.57	45.32
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	25.62	24.82
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	6.41	4.17
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	4.99	6.31
nucleus accumbens, adult, pool1	10037-101F1	19.31	10.50
occipital cortex - adult, donor10196	10172-103C1	51.51	18.54
occipital cortex, adult, donor10252	10163-103B1	34.35	24.96
occipital cortex, newborn, donor10223	10355-105E4	25.48	15.65
occipital lobe, adult, donor1	10076-102A4	15.74	16.01
occipital lobe, fetal, donor1	10073-102A1	56.64	52.35
occipital pole, adult, pool1	10036-101E9	5.60	3.63
olfactory region, adult	10195-103E6	12.80	10.51
optic nerve, donor1	10277-104E7	22.01	14.01
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	51.60	28.14
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	84.22	26.65
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	20.83	12.36
oral squamous cell carcinoma cell line:SAS	10544-107H4	25.07	8.78
osteoclastoma cell line:Hs 706.T	10704-109H2	8.23	4.41
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	36.44	22.42
osteosarcoma cell line:HS-Os-1	10558-107I9	24.60	8.27
ovary, adult, pool1	10020-101D2	29.09	14.76
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	34.83	9.72
pancreas, adult, donor1	10049-101G4	17.87	17.87
pancreatic carcinoma cell line:NOR-P1	10698-109G5	31.31	18.17
papillary adenocarcinoma cell line:8505C	10437-106E5	15.84	13.29
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	28.31	14.07
paracentral gyrus, adult, pool1	10035-101E8	17.30	6.41
parietal cortex, adult, donor10258	10373-105G4	14.68	11.74
parietal lobe - adult, donor10196	10171-103B9	18.81	12.23
parietal lobe, adult, donor10252	10157-103A4	28.22	13.68
parietal lobe, adult, pool1	10034-101E7	15.60	7.23
parietal lobe, fetal, donor1	10072-101I9	54.31	82.44
parietal lobe, newborn, donor10223	10356-105E5	27.67	16.82
parotid gland, adult	10199-103F1	15.42	8.63
penis, adult	10200-103F2	12.89	14.50
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	22.50	45.18
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	15.30	9.62
pineal gland - adult, donor10196	10179-103C8	26.45	20.00
pineal gland, adult, donor10252	10160-103A7	52.11	37.90
pineal gland, adult, donor10258	10377-105G8	10.03	18.19
pituitary gland - adult, donor10196	10180-103C9	36.42	36.42
pituitary gland, adult, donor10252	10162-103A9	74.01	56.81
pituitary gland, adult, donor10258	10378-105G9	11.07	22.13
placenta, adult, pool1	10021-101D3	14.08	8.71
plasma cell leukemia cell line:ARH-77	10840-111E3	32.71	22.78
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	14.32	7.78
pons, adult, pool1	10033-101E6	25.22	10.67
postcentral gyrus, adult, pool1	10032-101E5	10.03	6.71
promyelocytes/myelocytes PMC, donor1	12132-128D8	14.64	8.37
promyelocytes/myelocytes PMC, donor2	12136-128E3	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	23.47	0.00
prostate cancer cell line:DU145	10490-107B4	32.92	17.92
prostate cancer cell line:PC-3	10439-106E7	84.40	40.47
prostate, adult, pool1	10022-101D4	20.86	13.42
putamen, adult, donor10196	10176-103C5	24.79	22.66
putamen, adult, donor10252	10152-102I8	7.84	7.84
putamen, adult, donor10258, tech_rep1	10372-105G3	34.97	16.39
putamen, adult, donor10258, tech_rep2	10372-105G3	10.15	13.05
putamen, newborn, donor10223	10365-105F5	27.74	27.74
rectal cancer cell line:TT1TKB	10469-106I1	39.28	10.76
rectum, fetal, donor1	10067-101I4	30.60	22.26
renal cell carcinoma cell line:OS-RC-2	10411-106B6	16.96	13.57
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	15.74	14.50
retina, adult, pool1	10030-101E3	11.43	13.42
retinoblastoma cell line:Y79	10475-106I7	66.77	36.37
rhabdomyosarcoma cell line:KYM-1	10787-110H4	34.67	11.56
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	44.43	16.03
sacrococcigeal teratoma cell line:HTST	10695-109G2	4.55	1.52
salivary acinar cells, donor1	11771-123I7	39.17	20.07
salivary acinar cells, donor2	11772-123I8	33.18	16.52
salivary acinar cells, donor3	11773-123I9	15.89	11.25
salivary gland, adult, pool1	10093-102C3	7.44	11.44
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	12.98	12.31
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	12.46	13.75
seminal vesicle, adult	10201-103F3	26.45	21.69
serous adenocarcinoma cell line:JHOS-2	10639-108I9	47.61	32.31
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	12.83	5.79
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	15.05	11.04
serous cystadenocarcinoma cell line:HTOA	10693-109F9	18.54	7.12
signet ring carcinoma cell line:Kato III	10436-106E4	24.98	11.72
signet ring carcinoma cell line:NUGC-4	10483-107A6	57.16	28.64
skeletal muscle - soleus muscle, donor1	10282-104F3	14.19	10.64
skeletal muscle, adult, pool1	10023-101D5	20.51	10.79
skeletal muscle, fetal, donor1	10066-101I3	14.07	3.02
skin, adult, donor1	10074-102A2	20.36	20.36
skin, fetal, donor1	10065-101I2	30.30	39.77
small cell cervical cancer cell line:HCSC-1	10800-110I8	21.68	14.68
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	96.45	54.85
small cell lung carcinoma cell line:DMS 144	10841-111E4	33.73	14.46
small cell lung carcinoma cell line:LK-2	10541-107H1	49.94	29.17
small cell lung carcinoma cell line:NCI-H82	10842-111E5	38.93	36.35
small cell lung carcinoma cell line:WA-hT	10562-108A4	39.23	9.81
small intestine, adult, pool1	10024-101D6	23.53	12.18
small intestine, fetal, donor1	10064-101I1	17.69	17.20
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	61.55	43.08
smooth muscle, adult, pool1	10048-101G3	22.23	13.18
somatostatinoma cell line:QGP-1	10781-110G7	37.25	23.85
spinal cord - adult, donor10196	10181-103D1	36.02	32.81
spinal cord, adult, donor10252	10159-103A6	45.34	23.26
spinal cord, adult, donor10258	10369-105F9	29.06	8.99
spinal cord, fetal, donor1	10056-101H2	22.56	16.47
spinal cord, newborn, donor10223	10359-105E8	23.42	26.63
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	7.32	2.69
spleen, adult, pool1	10025-101D7	21.15	9.47
spleen, fetal, pool1	10044-101F8	15.41	7.63
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	51.45	23.19
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	43.67	16.52
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	16.07	9.09
squamous cell carcinoma cell line:T3M-5	10616-108G4	73.89	43.78
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	19.47	9.68
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	42.78	29.23
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	38.08	19.88
stomach, fetal, donor1	10062-101H8	23.50	23.50
submaxillary gland, adult	10202-103F4	10.82	14.81
substantia nigra - adult, donor10196	10178-103C7	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	35.73	20.56
substantia nigra, adult, donor10258	10371-105G2	10.86	10.35
substantia nigra, newborn, donor10223	10358-105E7	18.37	16.25
synovial sarcoma cell line:HS-SY-II	10441-106E9	46.31	27.28
temporal lobe, adult, pool1	10031-101E4	6.27	4.66
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	36.33	35.61
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	38.68	35.16
tenocyte, donor1	11763-123H8	5.93	3.14
tenocyte, donor2	11765-123I1	5.34	3.43
tenocyte, donor3	11768-123I4	7.41	4.45
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	103.34	39.26
teratocarcinoma cell line:NCR-G1	10798-110I6	47.17	19.27
teratocarcinoma cell line:PA-1	10807-111A6	55.95	17.82
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	66.27	22.47
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	76.77	37.82
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	86.38	57.69
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	31.92	37.13
testis, adult, pool1	10026-101D8	19.11	13.42
testis, adult, pool2	10096-102C6	15.34	10.83
thalamus - adult, donor10196	10168-103B6	27.60	19.87
thalamus, adult, donor10252	10154-103A1	35.63	21.57
thalamus, adult, donor10258, tech_rep1	10370-105G1	4.62	10.78
thalamus, adult, donor10258, tech_rep2	10370-105G1	11.53	6.92
thalamus, newborn, donor10223	10366-105F6	33.37	14.38
throat, adult	10209-103G2	18.73	14.48
throat, fetal, donor1	10061-101H7	22.85	17.98
thymic carcinoma cell line:Ty-82	10803-111A2	68.36	32.00
thymus, adult, pool1	10027-101D9	20.78	22.77
thymus, fetal, pool1	10043-101F7	34.29	30.03
thyroid carcinoma cell line:KHM-5M	10776-110G2	18.35	13.43
thyroid carcinoma cell line:TCO-1	10783-110G9	32.27	22.49
thyroid, adult, pool1	10028-101E1	21.65	15.12
thyroid, fetal, donor1	10060-101H6	17.93	15.03
tongue epidermis (fungiform papillae), donor1	10288-104F9	18.48	9.24
tongue, adult	10203-103F5	16.05	14.65
tongue, fetal, donor1	10059-101H5	21.28	11.43
tonsil, adult, pool1	10047-101G2	20.04	12.92
trachea, adult, pool1	10029-101E2	22.17	12.52
trachea, fetal, donor1	10058-101H4	21.93	17.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	13.82	9.21
transitional-cell carcinoma cell line:5637	10418-106C4	67.58	19.66
transitional-cell carcinoma cell line:JMSU1	10492-107B6	48.42	30.71
tridermal teratoma cell line:HGRT	10694-109G1	9.51	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	12.95	11.77
umbilical cord, fetal, donor1	10057-101H3	8.35	2.09
uterus, adult, pool1	10100-102D1	24.06	15.53
uterus, fetal, donor1	10055-101H1	22.52	17.41
vagina, adult	10204-103F6	23.26	10.34
vein, adult	10191-103E2	13.59	14.03
xeroderma pigentosum b cell line:XPL 17	10563-108A5	11.75	8.81